Duramed Research

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Duramed Research sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).

23 total trials none currently recruiting 23 completed later-stage tilt top decile by trial count

Duramed Research: 23 sponsored US clinical trials, none currently recruiting.

Duramed Research sponsors 23 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 23 completed. 14 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Contraception, with 1 trials.

Top-decile sponsor footprint

Duramed Research ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

23 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

23 total, page 1 of 1

COMPLETED Phase 2

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

NCT00924560

COMPLETED Phase 2

A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches

NCT00781456

COMPLETED Phase 3

Emergency Contraception Actual Use Study

NCT00777556

COMPLETED Phase 3

A Safety Extension Study of DR-OXY-301

NCT00782769

COMPLETED Phase 3

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

NCT00685113

COMPLETED Phase 3

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

NCT00615251

COMPLETED Phase 4

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

NCT00592839

COMPLETED Phase 2

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

NCT00394771

COMPLETED Phase 3

A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001

NCT00382408

COMPLETED Phase 3

Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

NCT00362479

COMPLETED Phase 3

A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal Atrophy

NCT00361569

COMPLETED Phase 3

A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes

NCT00272935

COMPLETED Phase 2

A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea

NCT00196391

COMPLETED Phase 2

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

NCT00117468

COMPLETED Phase 2

A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients

NCT00196339

COMPLETED Phase 3

Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

NCT00196326

COMPLETED Phase 3

A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens

NCT00117273

COMPLETED Phase 2

Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain

NCT00117481

COMPLETED Phase 2

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

NCT00196313

COMPLETED Phase 3

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

NCT00196365

COMPLETED Phase 3

A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

NCT00196378

COMPLETED Phase 2

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

NCT00196404

COMPLETED Phase 3

A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.

NCT00196352

Phase Distribution

PhaseTrial count
Phase 2 9
Phase 3 13
Phase 4 1

How the Duramed Research archive is shaped

23 indexed studies, none listed as recruiting (0% open); 23 completed (100%).

Phase mix: 14 late (III/IV) vs 9 early (I/II) (later-stage heavy).

Top condition: Contraception (1 trial), 3 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Duramed Research: archived-pipeline peers nationwide

Peers matched on 23 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Duramed Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0510152025 0%5%10%15%20%25% Total trials Recruiting share Duramed ResearchAMAG PharmaceuticalsAtriCureCara TherapeuticsCraig L Slingluff, Jr10xBio22nd Century Group23andMe3-C Institute for Social Development
Duramed Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Duramed Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 23 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Duramed Research page

23 registered trials is a research-attention snapshot, not an endorsement of Duramed Research or any single study.

  • None of Duramed Research's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Contraception is the condition Duramed Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Contraception trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Duramed Research pipeline card: 23 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.